BUDESHINE 200 INH: Budesonide Inhaler for Daily Asthma & COPD Control

 BUDESHINE 200 INH, manufactured by Steris Healthcare, contains Budesonide Inhalation I.P., an inhaled corticosteroid delivered via a metered-dose or dry powder inhaler device for the regular maintenance treatment of bronchial asthma. It is also used as part of a broader management plan for Chronic Obstructive Pulmonary Disease (COPD) in appropriate patients. Unlike quick-relief bronchodilators, budesonide works to control the underlying chronic airway inflammation that drives persistent respiratory symptoms, making it a cornerstone maintenance therapy rather than a rescue medication. It is prescribed for both adults and children who require daily, sustained anti-inflammatory support to keep asthma symptoms well controlled.

Why It's Important

Asthma is fundamentally an inflammatory airway disease, and even patients who feel symptom-free between flare-ups often have ongoing, low-grade airway inflammation that gradually worsens lung function if left untreated. Relying solely on bronchodilators for symptom relief without addressing this underlying inflammation increases the risk of frequent exacerbations, nighttime awakenings, and long-term decline in respiratory capacity. BUDESHINE 200 INH's role as a daily inhaled corticosteroid is central to modern asthma management guidelines, which emphasize consistent anti-inflammatory control as the foundation of long-term disease stability, helping reduce reliance on emergency bronchodilator use and lowering the risk of serious asthma attacks.

Key Benefits 

What are the benefits?

• Reduces chronic airway inflammation with regular daily use
• Helps prevent asthma exacerbations and reduces need for rescue inhaler use
• Supports improved long-term lung function and symptom control
• Suitable for both adult and pediatric maintenance therapy
• Manufactured under WHO-GMP and ISO 9001:2018 certified facility standards by Steris Healthcare, ensuring consistent potency and quality

Side Effects

Common side effects may include throat irritation, hoarseness of voice, dry cough, headache, or oral thrush if the mouth is not rinsed after each use.

Serious Side Effects 

Seek immediate medical attention for signs of a severe allergic reaction such as facial swelling or difficulty breathing, worsening breathlessness immediately after use, or signs of adrenal suppression with prolonged high-dose use, such as unusual fatigue or low blood pressure. In children, growth should be monitored with long-term use.

Available Substitute 

Several branded budesonide inhalation formulations are available in the Indian market at comparable strengths and delivery devices. Brand or device switches should only be made under physician guidance, as inhaler technique and design can affect drug delivery consistency.

Dosage Guidelines 

Dosage is individualized by the treating physician based on asthma severity and patient response, typically one to two inhalations twice daily. Patients should be trained on correct inhaler technique to ensure effective lung deposition, and should rinse the mouth with water after each use to minimize local side effects. Missed doses should not be doubled.

Precautions & Warnings

Use cautiously in patients with active or latent pulmonary tuberculosis, respiratory tract infections, or ocular herpes simplex due to the localized immunosuppressive effect of inhaled corticosteroids. It should not be used as a rescue medication during acute bronchospasm. Avoid abrupt discontinuation; taper gradually under physician guidance.

Mechanism of Action

Budesonide binds to intracellular glucocorticoid receptors in airway cells, modulating gene transcription to suppress pro-inflammatory mediators and reduce recruitment of inflammatory cells such as eosinophils and mast cells. This lowers airway mucosal edema, mucus hypersecretion, and hyperresponsiveness, addressing the chronic inflammatory basis of asthma.

Conclusion

BUDESHINE 200 INH by Steris Healthcare offers a well-established inhaled corticosteroid therapy for the long-term maintenance control of asthma and supportive COPD management. Consistent daily use under physician guidance is key to achieving stable symptom control and reducing exacerbation risk over time.